Main Goal of Our Research

Current Magnetic Resonance imaging studies are hindered by poor spatial resolution and limited metabolic information. Vigneron group’s mission is to develop new techniques for high-resolution anatomic, metabolic and microstructural imaging and to translate these novel methods into clinical radiological tools through collaborations with basic scientists, industry, clinical scientists, and physicians. To achieve this goal we are advancing basic imaging science through novel acquisition technique development and initial applications to preclinical and human volunteer testing.  We aim to utilize the state-of-the-art imaging hardware including high field 3T and 7 T MR scanners, 11T and 14 T NMR systems, and hyper-polarizer instrumentation to advance our understanding of human disease and create new methods to detect pathology and monitor response to therapy.

• Development of novel hardware and software techniques for 7 Tesla MRI, MR spectroscopy and MR diffusion imaging techniques

• Development of new Hyperpolarized C-13 MR techniques for metabolic imaging of cancer

• Improvement and Translation of 3 Tesla MR spectroscopy sequences for prostate and brain